ClearLight Biotechnologies, Inc.

ClearLight Biotechnologies provides contract research and development services to pharmaceutical companies who seek to improve the efficacy of potential drug candidates. The company provides pharmaceutical, biotechnology, and academic researchers with CLARITY Tissue Clearing, 3D immunostaining, and Tru3D image analysis services. The company is developing an automated instrumentation platform based on the CLARITY lipid-clearing technique developed by Dr. Deisseroth and colleagues at Stanford University. ClearLight empowers researchers to see more biology within the tissue microenvironment leading to improved diagnostic, prognostic, and predictive treatment of disease so we can all live healthier lives.